Chenghe Acquisition Co. (CHEA) to Combine with Taiwan Color Optics in $380M Deal
Chenghe (NASDAQ:CHEA) has entered into a definitive agreement to combine with precision glass-maker Taiwan Color Optics at an equity value of $380 million.
Taiwan-based Taiwan Color Optics was founded in 2009 and has a pair of R&D facilities in Taiwan working to produce precision glass, light and chip components for the electronics industry. ...READ MORE
Alpha Partners Technology Merger Corp. (APTM) Signs LOI with Glowforge
Alpha Partners Technology Merger Corp. (NASDAQ:APTM) announced in an 8-K this morning that it has signed a non-binding letter of intent (LOI) to combine with 3D printing firm Glowforge.
The SPAC has thus far released no other details on the proposed merger beyond that Glowforge’s existing shareholders would be expected to roll 100% of their equity into the combined entity. ...READ MORE
PowerUp Acquisition Corp. (PWUP) Sells Sponsor Economics
PowerUp (NASDAQ:PWUP) announced in an 8-K this morning that it has sold a large portion of its sponsor stake to SRIRAMA Associates in exchange for the investor taking on management responsibilities for the SPAC. ...READ MORE
Freedom Acquisition 1 Corp. (FACT) Closes Complete Solaria Deal
Freedom I (NYSE:FACT) announced this morning that it has closed its combination with residential solar developer Complete Solaria and the combined company’s shares and warrants are expected to trade on the Nasdaq under the symbols “CSLR” and “CSLRW” later today, July 18. ...READ MORE
Pardes Biosciences (PRDS) to Be Acquired by MediPacific for $2.02-$2.19 Per Share
Pardes Biosciences (NASDAQ:PRDS), which combined with FS Development Corp. II in December 2021, announced that it has agreed to be acquired by MediPacific for $2.02 to $2.19 per share for a premium of 8%-17% over its last closing price. ...READ MORE
Portage Fintech Acquisition Corporation (PFTA) Postpones Extension Vote Following Sponsor Change
Portage Fintech Acquisition Corporation (NASDAQ:PFTA) announced in a filing this morning that it has postponed its special shareholder meeting two days to 10 am ET July 21 from July 19.
Shareholders are to consider giving Portage Fintech a one-year transaction deadline extension, pushing the SPAC’s out to July 31, 2024 in exchange for no new contribution to its trust. ...READ MORE
Alpha Healthcare Acquisition Corp. III (ALPA) Closes Carmell Deal
Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that it has closed its combination with drug developer Carmell having secured shareholder approval at a special meeting on July 11.
The combined company’s shares and warrants are expected to begin trading on the Nasdaq under the symbols “CTCX” and “CTCXW” on July 17. ...READ MORE
Freedom Acquisition 1 Corp. (FACT) Adds Up to $80M to Complete Solaria Deal
Freedom I (NYSE:FACT) announced in an 8-K this morning that it has added financing arrangements worth up to about $80 million to its combination with residential solar developer Complete Solaria.
The new money fills a significant funding gap after Freedom I revealed it had 99% of its shares redeemed at the end of its completion vote, leaving it with just 335,492 shares remaining and about $3.5 million in trust. ...READ MORE
Freedom Acquisition 1 Corp. (FACT) Shareholders Approve Complete Solaria Deal
Freedom I (NYSE:FACT) announced this morning that its shareholders approved its combination with Complete Solaria at a special meeting July 11.
The parties have not released redemption figures nor a timeline for the close, but investors representing 76.9% of shares voted in favor of the deal. ...READ MORE
AltC Acquisition Corp (ALCC) to Combine with Oklo in $850M Deal
AltC (NYSE:ALCC) has entered into a definitive agreement to combine with fission technology firm Oklo at a pre-money equity value of $850 million.
Santa Clara, California-based Oklo is working to develop small-scale nuclear fission plants that could fit on just a two-acre footprint. ...READ MORE
XPAC Acquisition Corp. (XPAX) Sells Sponsor Economics Before Extension Vote
XPAC (NASDAQ:XPAX) announced in an 8-K filing that it has sold much of its sponsor economics and will change both name and management team.
J. Streicher Holdings is to purchase 4,400,283 of XPAC’s promote shares (80.1%) and 4,261,485 private placement warrants (100%) for $250,000 as it takes over as the new sponsor while also footing $25,000 in legal fees. ...READ MORE
Tastemaker Acquisition Corp. (TMKR) Adjourns Meeting, Changes Name to Priveterra II
Tastemaker Acquisition Corp. (NASDAQ:TMKR) announced in an 8-K this afternoon that adjourned its extension vote this morning and will reopen it at 3 pm ET July 11.
The SPAC has traded below its redemption rate $10.70 in recent weeks and last closed at $10.57. ...READ MORE
Alpha Healthcare III (ALPA) Adds FPA to Carmell Therapeutics Deal
Alpha Healthcare III (NASDAQ:ALPA) announced in an 8-K this morning that it has signed a forward purchase agreement (FPA) and a non-redemption agreement to support its combination with biotech firm Carmell. ...READ MORE
Galata Acquisition Corporation (GLTA) Shareholders Approve Marti Deal
Galata Acquisition Corporation (NASDAQ:GLTA) announced this morning that it secured shareholder approval for its combination with e-mobility company Marti at a shareholder vote July 6.
The parties expect to close the transaction July 10 and the combined company’s shares and warrants are set to begin trading on the NYSE American the following day under the symbols “MRT” and “MRTW”, respectively. ...READ MORE
Andretti Acquisition Corp. (WNNR) Signs LOI with Generative AI Company
Andretti (NYSE:WNNR) announced this morning that it has signed a non-binding letter-of-intent (LOI) to combine with a generative AI software company.
The SPAC expects this to progress to a definitive combination agreement in this quarter. ...READ MORE
Phoenix Biotech Acquisition Corp. (PBAX) Postpones Extension Vote
Phoenix Biotech (NASDAQ:PBAX) announced in an 8-K that it has postponed its extension vote from July 5 to 11 am ET July 7.
The SPAC’s existing transaction deadline falls on the following day, July 8, but its extension proposal would allow the Phoenix Biotech to extend this by one month up to six times for $0.03 per share contributions to its trust. ...READ MORE
East Resources Acquisition Company (ERES) Closes Abacus Life Combination
East Resources (NASDAQ:ERES) announced this morning that it has completed its combination with financial services firm after receiving shareholder approval at a special meeting on June 29.
The parties have not yet released redemption figures, but the SPAC had a minimum cash condition of just $1 million to clear. ...READ MORE
